首页> 外文期刊>Gastrointestinal endoscopy clinics of North America >Safety of endoscopy in patients with end-stage liver disease.
【24h】

Safety of endoscopy in patients with end-stage liver disease.

机译:终末期肝病患者内镜检查的安全性。

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with end-stage liver disease routinely undergo an upper endoscopy for the diagnosis and management of complications of portal hypertension. These cirrhotic patients inherently have additional risks and higher rates of complications secondary to their liver disease and the presence of portal hypertension. Additional considerations and precautions must be taken into account to ensure that the endoscopic procedure is performed with the minimal risks possible. This article discusses the management of cirrhotic patients undergoing endoscopy. It addresses clinical clues for identifying the cirrhotic patient, the use of medications and monitoring equipment for vital signs during endoscopy, blood product administration in acute upper gastrointestinal bleeding, and elective and urgent procedures to diagnose and treat cirrhotic patients.
机译:患有终末期肝病的患者通常接受上镜检查以诊断和处理门静脉高压症的并发症。这些肝硬化患者固有地具有额外的风险,其肝病和门静脉高压症继发的并发症发生率更高。必须考虑其他注意事项和预防措施,以确保以最小的风险进行内窥镜检查。本文讨论了接受内镜检查的肝硬化患者的管理。它介绍了识别肝硬化患者的临床线索,内窥镜检查期间生命迹象的药物和监测设备的使用,急性上消化道出血的血液制品管理以及诊断和治疗肝硬化患者的选择性和紧急程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号